Justlina-M Tablets: A Dual-Action Composition for Type 2 Diabetes Management
Justlina-M tablets from Cadbless Care, a subsidiary of Human Biolife India, consist of Linagliptin 2.5 mg and Metformin Hydrochloride 500 mg. The combination of the composition with a highly specific dosage helps in supporting better glycemic control.
Composition of Justlina-M Tablets
Each Justlina-M tablet contains:
- Linagliptin 2.5 mg, a DPP-4 (dipeptidyl peptidase-4) inhibitor
- Metformin Hydrochloride 500 mg, a biguanide antidiabetic agent
The two molecules address different aspects of blood sugar regulation, which is why this composition is widely valued in diabetes care.
How the Composition Works
Linagliptin
The drug acts as an inhibitor of the DPP-4 enzyme, which breaks down incretin hormones. Keeping incretin levels active helps increase insulin secretion in response to meals and helps reduce glucagon release. This medicine is perfect for everyday diabetes management because this action depends on glucose levels.
Metformin hydrochloride
Metformin hydrochloride has always been recommended by doctors to treat type 2 diabetes. It works by reducing hepatic (Liver) glucose production and also improves insulin sensitivity in the body. Cells use available insulin effectively.
Key uses of the Justlina-M tablet
- Helps in lowering blood sugar of individuals who are unable to lower it from diet, exercise, and single medication
- Blocks the enzyme of DPP-4, helping the pancreas to release more insulin to resist blood sugar
- Adds support to diet and exercise.
Why Choose the Linagliptin + Metformin Composition?
Complementary mechanism: Two molecules work on different pathways, which gives it broader glucose control than a single agent.
Convenient fixed-dose format: one tablet replaces separate medicines, which helps with adherence to the prescribed regimen.
Established clinical relevance: Linagliptin and metformin are well recognized by healthcare professionals; therefore, the medicine is relevant.
Support of long-term management: The medication helps in dealing with the long-term condition of type 2 diabetes.
Quality to rely on
Cadbless Care delivers scientifically developed pharmaceutical formulations designed to support healthcare professionals. Justlina-M Tablets are made with attention to quality, consistency, and compliance, so doctors, chemists and distributors can offer a product they have confidence in. Here are reasons to rely on:
- Specializes on cardiac-diabetic segments
- 10+ years of experience
- 2000+ brand portfolio
Dosage and Usage
- Medicine should be prescribed by the doctor.
- The right dose and duration are prescribed by the doctor based on individual needs and blood sugar response.
- Pairing the tablets with a balanced diet, regular physical activity and routine glucose monitoring.
PCD Pharma Franchise Opportunity
Cadbless Care is expanding its network through PCD Pharma Franchise partnerships across India. Justlina-M Tablets belong to the company’s Diabetic Range, one of the most in-demand therapeutic segments in the pharma market. Rising diabetes prevalence keeps demand for quality antidiabetic products strong, which makes this composition a valuable addition to any franchise portfolio.
Franchise partners benefit from:
- A growing diabetic and cardiac product range
- Quality-focused manufacturing backed by Human Biolife India Private Limited
- Dedicated support for distribution and promotion
- Products that suit prescription-driven demand